Illumina buys Jeff Bezos-backed cancer-testing firm Grail in deal worth $8 billion
September 21, 2020 at 06:54 AM EDT
Gene sequencing company Illumina will pay $8 billion in cash and stock to buy cancer screening startup Grail, the companies said.
